Applicant, as named in the Orange Book
Apothecon
Bristol-Myers Squibb Co · NYSE: BMY
Company and ticker: cliffwatch mapping, checked against SEC EDGAR · SEC filings
Products with listed protection
| Drug | Earliest generic entry |
|---|
None.
Recent events
- Ophthaine · Generic approved · ANDA 219294, Micro LabsApproved 20 Oct 2025Detected 25 Oct 2026
- Prolixin · Generic approved · ANDA 218769, Hetero Labs Ltd IiiApproved 18 Nov 2025Detected 25 Oct 2026
- Kenalog-10 · Generic approved · ANDA 218601, AlembicApproved 17 Oct 2025Detected 25 Oct 2026
Products without listed protection (3)
| Drug | Earliest generic entry |
|---|---|
| Kenalog-10 NDA 012041 triamcinolone acetonide | open now no listed protection |
| Kenalog-40 NDA 014901 triamcinolone acetonide | open now no listed protection |
| Kenalog-80 NDA 014901 triamcinolone acetonide | open now no listed protection |